SGMT
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ: SGMT · HEALTHCARE · BIOTECHNOLOGY
$7.71
+0.92% today
Updated 2026-05-08
Market cap
$476.11M
P/E ratio
—
P/S ratio
52.50x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$3 – $11
Volume
1.6M
Sagimet Biosciences Inc. Series A Common Stock (SGMT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-38.20%
ROA
-25.70%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-14.26M | — | — | — |
| 2020 | $0.00 | $-11.37M | — | — | — |
| 2021 | $0.00 | $-24.44M | — | — | — |
| 2022 | $0.00 | $-30.50M | — | — | — |
| 2023 | $2.00M | $-27.88M | 100.00% | -1,537.00% | -1,393.80% |
| 2024 | $0.00 | $-45.57M | — | — | — |
| 2025 | $0.00 | $-51.04M | — | — | — |